Company: THC
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0000070318-25-000039
Chunk: 93

Company: TENET HEALTHCARE CORP
Filing Date: 2025-07-30
Form: 10-Q
Item: Part I, Item 2
Chunk 93
---
 June 30, 2025.

38

Consolidated

Impairment and Restructuring Charges, and Acquisition-Related Costs

The following table presents our impairment and restructuring charges, and acquisition‑related costs:

Three Months EndedJune 30,Six Months EndedJune 30,2025202420252024Consolidated:  Impairment charges$3 $1 $3 $2 Restructuring charges10 18 25 32 Acquisition-related costs11 10 15 22 Total impairment and restructuring charges, and acquisition-related costs$24 $29 $43 $56 By segment:Hospital Operations$10 $15 $19 $30 Ambulatory Care14 14 24 26 Total impairment and restructuring charges, and acquisition-related costs$24 $29 $43 $56 

Restructuring charges during the three months ended June 30, 2025 included $4 million related to the transition of various administrative functions to our GBC, $3 million of contract and lease termination fees, $2 million of employee severance costs and $1 million of other restructuring costs. During the three months ended June 30, 2024, restructuring charges consisted of $7 million of legal costs related to the sale of certain businesses, $5 million of employee severance costs, $2 million related to the transition of various administrative functions to our GBC and $4 million of other restructuring costs.

Restructuring charges during the six months ended June 30, 2025 included $10 million of contract and lease termination fees, $7 million related to the transition of various administrative functions to our GBC, $4 million of employee severance costs, $3 million of legal costs related to the sale of certain businesses and $1 million of other restructuring costs. Restructuring charges for the six months ended June 30, 2024 consisted of $14 million of legal costs related to the sale of certain businesses, $6 million of employee severance costs, $5 million related to the transition of various administrative functions to our GBC and $7 million of other restructuring costs.

Acquisition-related costs consisted entirely of transaction costs for all of the periods in the table above.

Litigation and Investigation Costs

Litigation and investigation costs totaled $28 million and $45 million during the three and six months ended June